Farmacotherapie en farmaceutische zorg 1 (J000425A)
Summary
Samenvatting Farmacotherapie en Farmaceutische zorg 1, word doc.
1 view 1 purchase
Course
Farmacotherapie en farmaceutische zorg 1 (J000425A)
Institution
Universiteit Gent (UGent)
Deze samenvatting bundelt de essentiele zaken van het eerste master vak farmacotherapie en farmaceutische zorg 1. Dit vak wordt in het eerste masterjaar van de richting farmaceutische wetenschappen gedoceerd.
Het bevat eerste uitgiftebegeleidingen, doorverwijscriteria, interacties en alle andere ...
Farmacotherapie en farmaceutische zorg 1 (J000425A)
All documents for this subject (2)
Seller
Follow
lkfjqosidfj
Reviews received
Content preview
Farmaceutische zorg en farmacotherapie 1
2023 – 2024
Inhoudsopgave
1. Algemene inleiding.................................................................................................................................... 4
Wat is farmacotherapie?..................................................................................................................................4
Wat is farmaceutische zorg?...........................................................................................................................11
Zelfzorgadvies.................................................................................................................................................13
Vermijden van medicatiefouten – medicatiebewaking..................................................................................15
3. Interacties en geneesmiddelen................................................................................................................. 17
Interactiemechanismen..................................................................................................................................17
Gevolgen van interacties................................................................................................................................18
Interacties afhandelen....................................................................................................................................18
Arts contacteren.............................................................................................................................................20
4. Farmacokinetische interacties.................................................................................................................. 20
Interacties ter hoogte van de absorptie.........................................................................................................20
Interacties ter hoogte van de distributie........................................................................................................20
Interacties ter hoogte van de metabolisatie..................................................................................................21
Interacties ter hoogte van de excretie............................................................................................................23
Interacties ter hoogte van de PgP’s................................................................................................................23
1. Medicatiebegeleiding bij PPI’s.................................................................................................................. 77
Farmacologie van de PPI’s..............................................................................................................................77
Uitgiftebegeleiding.........................................................................................................................................77
Problematiek rond onnodig PPI gebruik.........................................................................................................78
2. Medicatiebewaking bij PPI’s..................................................................................................................... 80
CYP2C19..........................................................................................................................................................80
GM waarvan BB afhankelijk is van de gastro-intestinale pH..........................................................................80
3. Medicatiebegeleiding bij aminosalicylaten............................................................................................... 80
4. Maagklachten bij NSAID-gebruikers.......................................................................................................... 81
1. Astma vs COPD......................................................................................................................................... 97
2. Therapeutische klassen van inhalatiemedicatie........................................................................................98
ß2 agonisten (BA)...........................................................................................................................................98
Inhalatiecorticosteroïden...............................................................................................................................98
ICS + ß2 combinatie........................................................................................................................................98
Anticholinergica: muscarine antagonisten (MA)............................................................................................99
SABA + SAMA combinatie...............................................................................................................................99
LABA + LAMA combinatie...............................................................................................................................99
ICS + LABA + LAMA: single inhaler triple therapy...........................................................................................99
6. Medicatiebewaking................................................................................................................................ 107
Geneesmiddelinteracties..............................................................................................................................107
Contra-indicaties...........................................................................................................................................108
Zwangerschap en borstvoeding....................................................................................................................109
Andere aandachtspunten.............................................................................................................................109
7. Zelfzorg bij astma en COPD patiënten..................................................................................................... 110
Astma............................................................................................................................................................110
COPD.............................................................................................................................................................110
Insuline – begeleiding...................................................................................................................................111
Orale antidiabetica – begeleiding.................................................................................................................114
Pre-operatief beleid bij antidiabetica...........................................................................................................119
Extra informatie............................................................................................................................................119
Medicatiebewaking......................................................................................................................................120
Zelfzorg bij diabetici......................................................................................................................................122
Medicatiebegeleiding...................................................................................................................................125
Medicatiebewaking......................................................................................................................................126
Medicatiebegeleiding...................................................................................................................................128
Medicatiebewaking......................................................................................................................................131
3. Farmaceutische zorg bij anticonceptie en menopauzale klachten............................................................135
Medicatiebegeleiding...................................................................................................................................135
Medicatiebewaking......................................................................................................................................139
Noodanticonceptie.......................................................................................................................................140
4. Zelfzorg bij menstruatiepijn.................................................................................................................... 142
Niet medicamenteus advies.........................................................................................................................143
Medicamenteus advies.................................................................................................................................143
2. Behandeling van pijn.............................................................................................................................. 155
Niet medicamenteus....................................................................................................................................155
Medicamenteus............................................................................................................................................156
Cannabis/cannabinoïden..............................................................................................................................159
Opioïdencrisis in USA....................................................................................................................................159
Opioïdrotatie................................................................................................................................................160
3. Farmaceutische zorg bij pijn.................................................................................................................... 160
Paracetamol..................................................................................................................................................160
Opioïden.......................................................................................................................................................161
3. Farmaceutische zorg bij osteoporose...................................................................................................... 186
Achtergond...................................................................................................................................................186
Behandeling osteoporose.............................................................................................................................186
Farmaceutische zorg bij osteoporose...........................................................................................................188
Hoofdstuk 1
1. Algemene inleiding
Wat is farmacotherapie?
Doel: optimale behandeling van patiënten met geneesmiddelen.
GM = essentiële tool om klachten of aandoeningen te behandelen of te
voorkomen.
geneesmiddelengebruik, moet altijd rationeel gebeuren.
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller lkfjqosidfj. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $13.61. You're not tied to anything after your purchase.
